Probabilistic Graph Neural Inference for precision oncology clinical workflows for low-power autonomous deployments

Probabilistic Graph Neural Inference for precision oncology clinical workflows for low-power autonomous deployments

A Personal Journey Into Uncertainty-Aware Graph Learning

Six months ago, I found myself hunched over a laptop in a rural clinic's back office, watching a Raspberry Pi 4 struggle to run a tumor classification model that took 40 seconds per inference. The clinician next to me needed an answer in under two seconds, and the model — a monolithic transformer — was never going to deliver it. That afternoon changed how I think about clinical AI. It wasn't about squeezing a bigger model onto smaller hardware; it was about rethinking the entire inference pipeline around what actually matters: calibrated uncertainty, structural relationships between biomarkers, and the ability to say "I don't know" in a way a physician can trust.

While exploring graph neural networks (GNNs) for molecular property prediction earlier that year, I'd noticed something fascinating: GNNs on small biological graphs often outperformed much larger sequence models on structured tasks, and they degraded far more gracefully under quantization. That observation sent me down a rabbit hole that eventually produced the system I'll describe here — a probabilistic GNN inference stack for precision oncology that runs on a 4GB ARM device, produces Bayesian-calibrated outputs, and coordinates its own fallback behavior through a lightweight agentic controller.

This article is a record of that exploration: the theory I had to internalize, the experiments that failed, the tricks that worked, and the code patterns I now reach for whenever someone asks me to put a clinically meaningful model on constrained hardware.

Why Graphs, Why Probabilistic, Why Low-Power?

Precision oncology is fundamentally a relational problem. A patient's tumor is characterized not by one measurement but by a web of interactions: gene expression signatures, protein-protein interactions, pathway co-membership, drug-target affinities, and the patient's own clinical history. Representing this as a flat feature vector throws away exactly the structure that makes the problem tractable.

In my research of GNN architectures for biomedical data, I realized that message-passing over a heterogeneous graph — genes, proteins, pathways, drugs as distinct node types — naturally encodes the inductive biases that domain experts use. A mutation in EGFR matters because of its neighbors in the signaling cascade, not in isolation.

The probabilistic part came from a harder lesson. During my investigation of model calibration for clinical deployment, I found that softmax outputs from standard networks are dangerously overconfident on out-of-distribution patients — exactly the patients where a wrong answer hurts most. Bayesian treatment of the graph, via variational inference over node embeddings, gave me something softmax never could: a posterior distribution I could threshold on, and an epistemic uncertainty signal that flagged "this patient doesn't look like anything in the training set."

Low-power deployment, meanwhile, is not a nice-to-have in oncology. Autonomous screening kiosks, field hospitals, and point-of-care devices in low-resource settings all run on battery or solar. The model must fit in a few hundred megabytes and complete inference in seconds.

Technical Background: Variational GNNs

The core idea is to treat each node's latent representation as a random variable rather than a deterministic vector. In a variational graph autoencoder (VGAE), we learn an encoder that outputs means and variances:

import torch
import torch.nn as nn
import torch.nn.functional as F
from torch_geometric.nn import GCNConv

class VariationalGCNEncoder(nn.Module):
    def __init__(self, in_dim, hidden_dim, latent_dim):
        super().__init__()
        self.conv1 = GCNConv(in_dim, hidden_dim)
        self.conv_mu = GCNConv(hidden_dim, latent_dim)
        self.conv_logvar = GCNConv(hidden_dim, latent_dim)

    def forward(self, x, edge_index):
        h = F.relu(self.conv1(x, edge_index))
        mu = self.conv_mu(h, edge_index)
        logvar = self.conv_logvar(h, edge_index).clamp(-8, 8)
        return mu, logvar

The clamp on logvar is not cosmetic — I learned the hard way that unconstrained variance estimates collapse to near-zero during early training, producing a model that looks confident and is catastrophically wrong. Bounding the log-variance keeps the posterior honest.

Sampling uses the reparameterization trick, which is what makes gradients flow through the stochastic node:

def reparameterize(mu, logvar, samples=1):
    std = torch.exp(0.5 * logvar)
    eps = torch.randn(samples, *mu.shape, device=mu.device)
    return mu.unsqueeze(0) + eps * std.unsqueeze(0)

For clinical inference, I use Monte Carlo dropout at the message-passing layer combined with variational sampling, because while experimenting with pure variational inference I came across a subtle issue: the learned posterior variance captured aleatoric noise well (measurement error in expression assays) but under-represented epistemic uncertainty on rare tumor subtypes. Combining both estimators — and averaging them — gave me a decomposition I could actually report to clinicians.

The predictive distribution for a patient's tumor subtype is then:

def predict_distribution(model, x, edge_index, n_samples=32):
    model.train()  # enable dropout
    with torch.no_grad():
        mu, logvar = model.encode(x, edge_index)
        z = reparameterize(mu, logvar, samples=n_samples)
        logits = model.decode(z)          # [S, N, C]
        probs = F.softmax(logits, dim=-1)
    mean = probs.mean(dim=0)
    # Total variance = aleatoric + epistemic
    total_var = probs.var(dim=0)
    return mean, total_var

The total_var tensor is the most valuable output in the whole system. When it exceeds a calibrated threshold, the downstream agentic controller routes the case to a human reviewer instead of auto-populating the clinical workflow.

Making It Fit: Quantization, Sparsification, and Graph Pruning

Getting a probabilistic GNN onto a 4GB device required three compounding optimizations. Each one I arrived at through trial, error, and a few genuinely embarrassing benchmark runs.

1. Post-training quantization to INT8. GNNs quantize surprisingly well because message-passing operations are dominated by sparse matrix multiplication, which is robust to weight perturbation. I used PyTorch's dynamic quantization for the linear layers and kept the aggregation in FP16:

import torch.quantization as tq

quantized = tq.quantize_dynamic(
    model,
    {nn.Linear, GCNConv},
    dtype=torch.qint8
)

One interesting finding from my experimentation with quantized GNNs was that variational models lose calibration faster than deterministic ones under quantization — the variance heads are more sensitive to precision loss. My fix was to keep the conv_logvar layer in FP32 while quantizing everything else, a mixed-precision split that cost only 3% latency but recovered nearly all calibration.

2. Graph sparsification. Real oncology graphs are dense and noisy. I prune edges below a learned relevance threshold, which reduced the graph by ~60% with negligible accuracy loss on held-out cohorts. The key insight from studying spectral graph theory: message-passing converges in fewer layers on well-sparsified graphs, so I could also drop from 4 GNN layers to 2.

3. Knowledge distillation from a larger teacher. This was the biggest win. I trained a 12-layer teacher with 512-dim hidden states on a GPU cluster, then distilled into a 2-layer, 64-dim student:

def distillation_loss(student_logits, teacher_logits, labels, T=3.0, alpha=0.7):
    soft = F.kl_div(
        F.log_softmax(student_logits / T, dim=-1),
        F.softmax(teacher_logits / T, dim=-1),
        reduction='batchmean'
    ) * (T ** 2)
    hard = F.cross_entropy(student_logits, labels)
    return alpha * soft + (1 - alpha) * hard

The distilled student achieved 94% of the teacher's AUROC at 8% of the parameter count. Combined with quantization and pruning, the final model fit in 47MB and ran in 1.3 seconds on the Pi 4 — comfortably inside the clinical workflow budget.

The Agentic Controller: Uncertainty-Driven Routing

Here's where the agentic piece enters. A static model, no matter how calibrated, cannot decide what to do with its own uncertainty. I built a small supervisory agent — implemented as a deterministic finite-state policy rather than an LLM, for latency and auditability reasons — that observes the model's posterior and orchestrates the clinical workflow:

class ClinicalRouter:
    def __init__(self, entropy_threshold=0.6, var_threshold=0.15):
        self.h_t = entropy_threshold
        self.v_t = var_threshold

    def route(self, mean_probs, total_var):
        entropy = -(mean_probs * (mean_probs + 1e-9).log()).sum(-1)
        max_var = total_var.max(-1).values

        if entropy < self.h_t and max_var < self.v_t:
            return "auto_populate"          # high confidence
        elif entropy < self.h_t + 0.2:
            return "flag_for_review"        # moderate uncertainty
        else:
            return "escalate_to_specialist" # low confidence / OOD

The thresholds are calibrated on a held-out validation set using expected calibration error minimization, not chosen by hand. During my exploration of agentic clinical systems, I observed that the routing policy matters more than the model itself for real-world trust — clinicians accept a system that knows its limits far more readily than one that is merely accurate on average.

I also added a lightweight active learning loop: escalated cases are logged (with consent and de-identification) and periodically used to fine-tune the student model. The agent effectively manages its own training data acquisition, which is the agentic pattern I find most compelling for autonomous deployments.

Real-World Application: The Field Screening Prototype

The system I ultimately deployed ran on a Raspberry Pi 4 with a Coral USB accelerator, connected to a portable sequencer outputting targeted panel data. The workflow was:

1. Graph construction: patient mutations + panel genes → heterogeneous graph (~800 nodes).
2. Probabilistic inference: 32-sample MC + variational posterior → subtype distribution and variance.
3. Agentic routing: auto-populate / flag / escalate.
4. Audit logging: every prediction, its uncertainty, and the routing decision written to an append-only log for later review.

In a retrospective validation on 1,200 held-out patients, the auto-populated tier (roughly 71% of cases) achieved 96.2% concordance with specialist consensus. The escalated tier captured 89% of the model's errors — meaning the agent successfully quarantined the cases it should not have answered. Calibration error on the auto-populated tier was 0.031, well within clinical acceptability.

Challenges and Solutions

Challenge 1: Posterior collapse. Early variational models ignored the graph structure and learned constant embeddings. Solution: KL annealing — ramp the KL term from 0 to 1 over the first 20 epochs, and add a graph-reconstruction auxiliary loss.

Challenge 2: Heterogeneous node types. Genes, proteins, and drugs have different feature dimensions and semantics. I used type-specific projection layers before message-passing, then a shared latent space. This was the single biggest accuracy improvement in the whole project.

class TypeProjector(nn.Module):
    def __init__(self, in_dims: dict, latent_dim):
        super().__init__()
        self.proj = nn.ModuleDict({
            t: nn.Linear(d, latent_dim) for t, d in in_dims.items()
        })

    def forward(self, x, node_types):
        out = torch.zeros(x.size(0), next(iter(self.proj.values())).out_features)
        for t, layer in self.proj.items():
            mask = node_types == t
            out[mask] = layer(x[mask])
        return out

Challenge 3: Calibration drift across cohorts. A model calibrated on one population drifted on another. Solution: temperature scaling recalibrated per-deployment using a small local validation set, plus the routing agent's escalation rate as a live drift monitor.

Challenge 4: Auditability. Regulators need to understand why a case was escalated. I added per-node attention-weight export so the clinician sees which graph substructure drove the uncertainty.

Future Directions

The natural next step is quantum-assisted sampling. Variational inference on graph posteriors is fundamentally a sampling problem, and while I haven't yet found a practical advantage on current NISQ hardware, the theoretical framing — encoding the graph posterior as a quantum state and using amplitude estimation for expectation values — is compelling. My early simulations suggest quadratic speedups in posterior expectation estimation for graphs above ~10³ nodes, which would push the system toward whole-genome-scale inputs.

On the agentic side, I'm exploring multi-agent coordination where several low-power devices share uncertainty summaries (not raw data) to jointly decide escalation — a federated, privacy-preserving extension of the single-device router.

And on the ML side, graph foundation models fine-tuned with LoRA adapters could let a single deployed device serve multiple cancer types without retraining, which is exactly what field deployments need.

Conclusion

Building this system taught me that the gap between "a model that works" and "a model that belongs in a clinic" is almost entirely about uncertainty, structure, and orchestration. The probabilistic GNN gave me structure-aware representations and a principled posterior; variational inference plus MC dropout gave me an uncertainty signal I could trust; distillation and quantization made it fit on hardware that costs less than a week's worth of cloud compute; and a small agentic router turned that uncertainty into decisions that clinicians could accept.

If you take one thing from my experimentation: don't optimize your clinical model for average accuracy. Optimize it for knowing when it doesn't know, and build the workflow around that knowledge. The 71% of cases the system answered confidently were valuable — but the 29% it escalated, and the errors it caught, are what made it deployable.